Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder

被引:230
作者
Young, AH [1 ]
Gallagher, P [1 ]
Watson, S [1 ]
Del-Estal, D [1 ]
Owen, BM [1 ]
Ferrier, IN [1 ]
机构
[1] Newcastle Univ, Stanley Res Ctr, Sch Neurol Neurobiol & Psychiat, Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
bipolar disorder; antiglucocorticoid; glucocorticoid receptor; cortisol; mood; memory;
D O I
10.1038/sj.npp.1300471
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
High cortisol levels are found in severe mood disorders, particularly bipolar disorder. Hypercortisolaemia may cause or exacerbate both neurocognitive impairment and depressive symptoms, We hypothesized that antiglucocorticoid treatments, particularly corticosteroid receptor antagonists, would improve neurocognitive functioning and attenuate depressive symptoms in this disorder. To test this hypothesis, 20 bipolar patients were treated with 600 mg/day of the corticosteroid receptor antagonist mifelpristone (RU-486) or placebo for I week in a double-blind crossover design. Over the total 6 weeks of the study, neurocognitive and neuroendocrine function were evaluated at baseline, days 21 and 42, Mood symptoms were evaluated weekly. Nineteen subjects completed the protocol; there were no drop-outs due to adverse events. Following treatment with mifelpristone, selective improvement in neurocognitive functioning was observed. Spatial working memory performance was significantly improved compared to placebo (19.8% improvement over placebo). Measures of verbal fluency and spatial recognition memory were also improved after mifepristone. Beneficial effects on mood were found; Hamilton Depression Rating Scale scores were significantly reduced compared to baseline (mean reduction of 5.1 points) as were Montgomery-Asberg Depression Rating Scale scores (mean reduction of 6.05 points). No significant change occurred after placebo. These data require replication but provide preliminary evidence that glucocorticoid receptor antagonists may have useful cognitive-enhancing and possibly antidepressant properties in bipolar disorder.
引用
收藏
页码:1538 / 1545
页数:8
相关论文
共 43 条
[1]  
Altman D., 2000, STAT CONFIDENCE
[2]  
[Anonymous], 2004, Neuropsychological Assessment
[3]   Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis [J].
Bachmann, CG ;
Linthorst, ACE ;
Holsboer, F ;
Reul, JMHM .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (06) :1056-1067
[4]   An open label trial of C-1073 (mifepristone) for psychotic major depression [J].
Belanoff, JK ;
Rothschild, AJ ;
Cassidy, F ;
DeBattista, C ;
Baulieu, EE ;
Schold, C ;
Schatzberg, AF .
BIOLOGICAL PSYCHIATRY, 2002, 52 (05) :386-392
[5]   Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review [J].
Brown, ES ;
Bobadilla, L ;
Rush, AJ .
BIPOLAR DISORDERS, 2001, 3 (01) :23-29
[6]  
Cegalis J., 1991, Vigil: Software for the Assessment of Attention
[7]   Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe [J].
de Quervain, DJF ;
Henke, K ;
Aerni, A ;
Treyer, V ;
McGaugh, JL ;
Berthold, T ;
Nitsch, RM ;
Buck, A ;
Roozendaal, B ;
Hock, C .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (06) :1296-1302
[8]   Acute cortisone administration impairs retrieval of long-term declarative memory in humans [J].
de Quervain, DJF ;
Roozendaal, B ;
Nitsch, RM ;
McGaugh, JL ;
Hock, C .
NATURE NEUROSCIENCE, 2000, 3 (04) :313-314
[9]   The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism [J].
Dorn, LD ;
Burgess, ES ;
Friedman, TC ;
Dubbert, B ;
Gold, PW ;
Chrousos, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) :912-919
[10]   Neuropsychological function in euthymic patients with bipolar disorder [J].
Ferrier, IN ;
Stanton, BR ;
Kelly, TP ;
Scott, J .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 175 :246-251